Aromatase inhibitors in stimulated IVF cycles
<p>Abstract</p> <p>Aromatase inhibitors have been introduced as a new treatment modality that could challenge clomiphene citrate as an ovulation induction regiment in patients with PCOS. Although several randomized trials have been conducted regarding their use as ovulation inducti...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-06-01
|
| Series: | Reproductive Biology and Endocrinology |
| Online Access: | http://www.rbej.com/content/9/1/85 |
| _version_ | 1818275474629984256 |
|---|---|
| author | Tournaye Herman Bosch Ernesto Pados George Humaidan Peter Polyzos Nikolaos P Papanikolaou Evangelos G Tarlatzis Basil |
| author_facet | Tournaye Herman Bosch Ernesto Pados George Humaidan Peter Polyzos Nikolaos P Papanikolaou Evangelos G Tarlatzis Basil |
| author_sort | Tournaye Herman |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Aromatase inhibitors have been introduced as a new treatment modality that could challenge clomiphene citrate as an ovulation induction regiment in patients with PCOS. Although several randomized trials have been conducted regarding their use as ovulation induction agents, only few trials are available regarding their efficacy in IVF stimulated cycles. Current available evidence support that letrozole may have a promising role in stimulated IVF cycles, either when administered during the follicular phase for ovarian stimulation. Especially for women with poor ovarian response, letrozole appears to have the potential to increase clinical pregnancy rates when combined with gonadotropins, whereas at the same time reduces the total gonadotropin dose required for ovarian stimulation. However, given that in all of the trials letrozole has been administered in GnRH antagonist cycles, it is intriguing to test in the future how it may perform when used in GnRH agonist cycles. Finally administration of letrozole during luteal phase in IVF cycles offers another treatment modality for patients at high risk for OHSS taking into account that it drastically reduces estradiol levels</p> |
| first_indexed | 2024-12-12T22:30:20Z |
| format | Article |
| id | doaj.art-202c1c7668244ba2b858875e1a5dcd75 |
| institution | Directory Open Access Journal |
| issn | 1477-7827 |
| language | English |
| last_indexed | 2024-12-12T22:30:20Z |
| publishDate | 2011-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Reproductive Biology and Endocrinology |
| spelling | doaj.art-202c1c7668244ba2b858875e1a5dcd752022-12-22T00:09:37ZengBMCReproductive Biology and Endocrinology1477-78272011-06-01918510.1186/1477-7827-9-85Aromatase inhibitors in stimulated IVF cyclesTournaye HermanBosch ErnestoPados GeorgeHumaidan PeterPolyzos Nikolaos PPapanikolaou Evangelos GTarlatzis Basil<p>Abstract</p> <p>Aromatase inhibitors have been introduced as a new treatment modality that could challenge clomiphene citrate as an ovulation induction regiment in patients with PCOS. Although several randomized trials have been conducted regarding their use as ovulation induction agents, only few trials are available regarding their efficacy in IVF stimulated cycles. Current available evidence support that letrozole may have a promising role in stimulated IVF cycles, either when administered during the follicular phase for ovarian stimulation. Especially for women with poor ovarian response, letrozole appears to have the potential to increase clinical pregnancy rates when combined with gonadotropins, whereas at the same time reduces the total gonadotropin dose required for ovarian stimulation. However, given that in all of the trials letrozole has been administered in GnRH antagonist cycles, it is intriguing to test in the future how it may perform when used in GnRH agonist cycles. Finally administration of letrozole during luteal phase in IVF cycles offers another treatment modality for patients at high risk for OHSS taking into account that it drastically reduces estradiol levels</p>http://www.rbej.com/content/9/1/85 |
| spellingShingle | Tournaye Herman Bosch Ernesto Pados George Humaidan Peter Polyzos Nikolaos P Papanikolaou Evangelos G Tarlatzis Basil Aromatase inhibitors in stimulated IVF cycles Reproductive Biology and Endocrinology |
| title | Aromatase inhibitors in stimulated IVF cycles |
| title_full | Aromatase inhibitors in stimulated IVF cycles |
| title_fullStr | Aromatase inhibitors in stimulated IVF cycles |
| title_full_unstemmed | Aromatase inhibitors in stimulated IVF cycles |
| title_short | Aromatase inhibitors in stimulated IVF cycles |
| title_sort | aromatase inhibitors in stimulated ivf cycles |
| url | http://www.rbej.com/content/9/1/85 |
| work_keys_str_mv | AT tournayeherman aromataseinhibitorsinstimulatedivfcycles AT boschernesto aromataseinhibitorsinstimulatedivfcycles AT padosgeorge aromataseinhibitorsinstimulatedivfcycles AT humaidanpeter aromataseinhibitorsinstimulatedivfcycles AT polyzosnikolaosp aromataseinhibitorsinstimulatedivfcycles AT papanikolaouevangelosg aromataseinhibitorsinstimulatedivfcycles AT tarlatzisbasil aromataseinhibitorsinstimulatedivfcycles |